Redcare Pharmacy NV (LON:0RJT)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 1.07B -22.8% |
| Revenue (ttm) | 2.77B +20.2% |
| Net Income | -36.17M |
| EPS | -1.80 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 157.34 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 186 |
| Open | 59.88 |
| Previous Close | 59.50 |
| Day's Range | 59.05 - 61.80 |
| 52-Week Range | 30.20 - 90.00 |
| Beta | 1.42 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
About Redcare Pharmacy NV
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands. [Read more]
Financial Performance
In 2025, Redcare Pharmacy NV's revenue was 2.94 billion, an increase of 24.06% compared to the previous year's 2.37 billion. Losses were -37.70 million, -17.14% less than in 2024.
Financial numbers in EUR Financial StatementsNews
Redcare Pharmacy NV Earnings Call Transcript: Q2 2026
Revenue grew 20% year-over-year in Q2, with strong Rx performance and improved profitability. 2026 guidance was raised for both revenue and EBITDA margin, while automation and AI initiatives support long-term growth. Regulatory and market changes are being managed proactively.
Redcare Pharmacy NV Slides: Q2 2026
Redcare Pharmacy NV has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Redcare Pharmacy NV Quarterly report: Q2 2026
Redcare Pharmacy NV has published its Q2 2026 quarterly earnings report on July 29, 2026.
Redcare Pharmacy NV Earnings release: Q2 2026
Redcare Pharmacy NV released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Redcare Pharmacy NV Earnings Call Transcript: Q1 2026
Q1 2026 saw 18% revenue growth to €849M, with strong Rx and non-Rx performance, improved EBITDA margin, and a rebound in German non-Rx. Guidance remains unchanged amid regulatory uncertainty and early-year volatility, with continued investment in IT and marketing optimization.
Redcare Pharmacy NV Slides: Q1 2026
Redcare Pharmacy NV has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Redcare Pharmacy NV Quarterly report: Q1 2026
Redcare Pharmacy NV has published its Q1 2026 quarterly earnings report on May 6, 2026.
Redcare Pharmacy NV Earnings release: Q1 2026
Redcare Pharmacy NV released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Redcare Pharmacy NV Earnings Call Transcript: Q4 2025
Full-year revenues rose 24% to EUR 2.9 billion, driven by strong Rx growth and logistics expansion. 2026 guidance targets 13%-15% sales growth, Rx Germany revenues above EUR 670 million, and an adjusted EBITDA margin of at least 2.5%.
Redcare Pharmacy NV Earnings release: Q4 2025
Redcare Pharmacy NV released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.
Redcare Pharmacy NV Annual report: Q4 2025
Redcare Pharmacy NV has published its Q4 2025 annual report on March 4, 2026.
Redcare Pharmacy NV Slides: Q4 2025
Redcare Pharmacy NV has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.
German online drug retailer Redcare Pharmacy names Hendrik Krampe as CFO
German online drug retailer Redcare Pharmacy on Monday named Hendrik Krampe as its chief financial officer, effective December 1.
Redcare Pharmacy NV Earnings Call Transcript: Q3 2025
Sales grew 27% year-over-year with strong gains in both Rx and non-Rx segments, and adjusted EBITDA margin reached 2.1% year-to-date. Cash flow and liquidity remain robust, supporting ongoing investments in logistics and automation, while full-year guidance is reiterated.
Redcare Pharmacy NV Quarterly report: Q3 2025
Redcare Pharmacy NV has published its Q3 2025 quarterly earnings report on October 30, 2025.
Redcare Pharmacy NV Slides: Q3 2025
Redcare Pharmacy NV has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 30, 2025.
CTP Builds 30,000 sqm of Distribution Space for Redcare Pharmacy, Europe's Leading Online Pharmacy
AMSTERDAM--(BUSINESS WIRE)--Regulatory News: CTP, Europe's largest listed developer, owner, and manager of industrial and logistics properties by gross lettable area (GLA), today began the constructio...
Redcare Pharmacy aims for higher 2024 sales after positive annual core earnings
Redcare Pharmacy on Tuesday forecast higher sales for 2024 after the online pharmacy operator posted upbeat adjusted annual core earnings, supported by a growing number of prescription sales.